stockrow
Friday 6 November 2026
Export BFLY’s income statement to Excel — free account
Butterfly Network, Inc.
BFLY Healthcare Medical Devices
Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024.
- Revenue
- +51.7%
- EPS
- +63.0%
- Free cash flow
- +12.6%
Quarter to September 2026, against a year earlier
6.35
0.28
+4.61%
Follow BFLY
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
9.62 | 10.07 | 19.68 | 19.37 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
103.98 | (74.59) | (135.65) | (1,053.76) | |
P/B ratio |
4.79 | 5.42 | 11.65 | 12.95 | |
Price to Tangible BV |
4.98 | 5.63 | 12.09 | 13.42 | |
EV/Sales |
8.63 | 9.25 | 19.05 | 18.82 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(66.34) | (63.84) | (88.93) | (99.13) | |
EV/FCF |
(52.50) | (50.49) | (76.18) | (84.19) | |
Quick Ratio |
2.72 | 2.74 | 2.72 | 2.35 | |
Current Ratio |
3.83 | 4.02 | 4.06 | 3.58 | |
Net Debt/EBITDA |
10.06 | 11.44 | 10.38 | 10.22 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.35 | 0.34 | 0.38 | 0.43 | |
Operating CF/Net income |
(0.59) | 1.10 | 1.26 | 0.18 | |
Capex/Depreciation |
(0.62) | (0.52) | (0.59) | (0.71) | |
Interest Coverage |
(42.85) | (49.72) | (48.45) | (47.81) | |
Research and Development Expense of Revenue |
29.58% | 35.95% | 32.33% | 31.20% | |
Selling, General and Administrative Expense of Revenue |
73.90% | 83.81% | 69.98% | 71.06% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
20.19% | 20.89% | 21.58% | 20.65% | |
Graham Net Nets |
0.16 | 0.14 | 0.07 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.16%) | (7.43%) | (3.44%) | (2.32%) | |
Free Cash Flow Yield |
(1.71%) | (1.82%) | (1.27%) | (1.15%) | |
Revenue per Share |
0.13 | 0.10 | 0.12 | 0.12 | |
Operating CF per Share |
0.04 | (0.05) | (0.06) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.03 | (0.06) | (0.07) | (0.01) | |
Cash per Share |
0.61 | 0.54 | 0.48 | 0.46 | |
Shareholders Equity per Share |
0.79 | 0.75 | 0.72 | 0.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.79 | 0.75 | 0.72 | 0.69 | |
Free Cash Flow |
7.95 | (14.84) | (17.24) | (3.41) | |
Working Capital |
183.99 | 180.21 | 179.34 | 175.68 | |
Capital Expenditures |
(1.08) | (0.95) | (0.97) | (1.14) | |
Net Current Asset Value |
148.55 | 145.09 | 144.35 | 140.14 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.03 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
23.77 | 22.55 | 29.54 | 30.90 | |
Average Payables |
4.85 | 2.55 | 3.42 | 4.48 | |
Average Inventory |
66.09 | 64.31 | 63.73 | 60.91 | |
Average Assets |
276.31 | 302.17 | 298.14 | 288.99 | |
Average Common Equity |
182.41 | 215.46 | 211.10 | 194.14 |
Columns are period end dates · fundamentals updated 6 Nov 2026